...because monitoring the brain matters!


We believe that continued development in neuromonitoring provides important insight into the well-being of the brain of patients in the OR, ICU, ER, and other clinical settings. Improved neurological outcomes and cerebral protection are the milestones we must achieve to advance patient care. NeuroWave is at the forefront of this emerging field and is committed to the advancement and commercialization of intelligent brain monitors for immediate, easy-to-use and reliable assessment of the brain, similar to what is currently available for the heart.

NeuroWave is also committed to innovating the delivery of intravenous sedatives and analgesics by better controlling their administration through our WAVCNS measure of brain activity. This technology acts as an auto-pilot for anesthesia and sedation delivery, which represents a paradigm shift for medical professionals who will now be able to titrate the drugs to a desired effect instead of a dose. With results including improved patient safety and outcome, and reduction of the care provider’s workload, our control technology will transform the practice of anesthesia to benefit patients worldwide.​


Our R&D efforts are dedicated to continually improving our current product line and adding to our growing portfolio of innovative patient monitoring technologies. Our portable and easy-to-use systems incorporate state-of-the-art digital acquisition and sophisticated signal processing algorithms of brain waves and other biosignals for continuous, automated, and reliable assessment of the patient’s state.

We are focused on the following core research areas:


Our advanced brain monitors are supported by the following advanced technologies to ensure robust and user-friendly performance.